Sornsakrin M, Wenner K, Ganschow R
Department of Pediatrics, Division of Pediatric Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Eur J Pediatr. 2009 Jul;168(7):825-31. doi: 10.1007/s00431-008-0843-6. Epub 2008 Oct 7.
We report on two brothers with hyperimmunoglobulinemia D (patient 1: serum immunoglobulin D [IgD] concentration initially 61 IU/ml, later on 340 IU/ml; patient 2: serum IgD concentration 144 IU/ml; normal <100 IU/ml, 97th centile) and periodic fever syndrome (HIDS). Both are compound heterozygous for the mevalonate kinase (MVK) mutations V377I and I268T. They developed significant B cell cytopenia (7%, 129/microl and 11%, 132/microl, respectively; normal ranges 12-22%, 300-500/microl) with hypogammaglobulinemia (IgG 5.48 g/l and IgG 5.22 g/l, respectively; normal range IgG 6-13 g/l). Furthermore, the clinical spectrum shows an interesting atypical autoinflammatory symptomatology. The therapy consisted of prednisone, azathioprine, and intravenous immunoglobulins (IVIG), which results in reduced incidence and severity of febrile attacks.
The pathogenesis and clinical presentation of HIDS is still not fully understood and show a great variability. To our knowledge, severe B cell cytopenia in children with HIDS has not been reported before. Furthermore, the therapy of febrile episodes is still performed on an individual basis in affected patients.
我们报告了两名患有高免疫球蛋白D血症(患者1:血清免疫球蛋白D [IgD]浓度最初为61 IU/ml,后来为340 IU/ml;患者2:血清IgD浓度为144 IU/ml;正常范围<100 IU/ml,第97百分位数)和周期性发热综合征(HIDS)的兄弟。两人都是甲羟戊酸激酶(MVK)突变V377I和I268T的复合杂合子。他们出现了明显的B细胞减少(分别为7%,129/微升和11%,132/微升;正常范围为12 - 22%,300 - 500/微升)以及低丙种球蛋白血症(IgG分别为5.48 g/l和5.22 g/l;正常范围IgG为6 - 13 g/l)。此外,临床谱显示出一种有趣的非典型自身炎症症状。治疗包括泼尼松、硫唑嘌呤和静脉注射免疫球蛋白(IVIG),这使得发热发作的发生率和严重程度降低。
HIDS的发病机制和临床表现仍未完全明确,且具有很大的变异性。据我们所知,此前尚未报道过HIDS患儿出现严重B细胞减少的情况。此外,对于受影响患者发热发作的治疗仍基于个体情况进行。